Antileishmanial Activity of the Estrogen Receptor Modulator Raloxifene

BACKGROUND: The treatment of leishmaniasis relies mostly on parenteral drugs with potentially serious adverse effects. Additionally, parasite resistance in the treatment of leishmaniasis has been demonstrated for the majority of drugs available, making the search for more effective and less toxic dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Reimão, Juliana Q., Miguel, Danilo C., Taniwaki, Noemi N., Trinconi, Cristiana T., Yokoyama-Yasunaka, Jenicer K. U., Uliana, Silvia R. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014391/
https://www.ncbi.nlm.nih.gov/pubmed/24810565
http://dx.doi.org/10.1371/journal.pntd.0002842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014391/
https://www.ncbi.nlm.nih.gov/pubmed/24810565
http://dx.doi.org/10.1371/journal.pntd.0002842

Ejemplares similares